Aspen Grove Capital, LLC Merck & Co., Inc. Transaction History
Aspen Grove Capital, LLC
- $472 Billion
- Q4 2024
A detailed history of Aspen Grove Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aspen Grove Capital, LLC holds 3,304 shares of MRK stock, worth $295,708. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,304
Previous 3,729
11.4%
Holding current value
$295,708
Previous $426 Million
22.3%
% of portfolio
0.07%
Previous 0.09%
Shares
9 transactions
Others Institutions Holding MRK
# of Institutions
3,952Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.8 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.23 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.48 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $227B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...